Skip to content

Study on the Regulation of Thyroid Function and Outcome of Nodules by Xiaoying Sanjie Formula in Patients with Subclinical Thyroid Dysfunction Complicated with Benign Nodules Based on the Theory of "Goiter Caused by Phlegm-Stasis and Liver Qi Disorder"

Study on the Regulation of Thyroid Function and Outcome of Nodules by Xiaoying Sanjie Formula in Patients with Subclinical Thyroid Dysfunction Complicated with Benign Nodules Based on the Theory of "Goiter Caused by Phlegm-Stasis and Liver Qi Disorder"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001015
Enrollment
Unknown
Registered
2026-04-17
Start date
2026-04-27
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subclinical Thyroid Dysfunction Complicated with Benign Nodules

Interventions

Experimental group.:All study participants received external treatment with Xiaoying Sanjie Formula.

Sponsors

Shenzhen Luohu Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Based on the Chinese "Guidelines for the Diagnosis and Treatment of Thyroid Nodules and Differentiated Thyroid Cancer" (2nd edition), the inclusion criteria were set as follows: age 18-65 years, ultrasound-confirmed benign thyroid nodules (TI-RADS 2-3 category), thyroid dysfunction (TSH mildly elevated/FT3/FT4 mildly abnormal/TPOAb/TGAb mildly elevated) or normal thyroid function but nodule diameter = 1 cm and the patient has the willingness to undergo intervention and can cooperate with the 12-week intervention and follow-up process.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1) A definitive diagnosis of a malignant tumor; 2) co-occurrence of significant damage to vital organs, mental illness, significant abnormalities in blood clotting and thyroid function; 3) pregnant women; 4) individuals deemed by researchers to have reduced eligibility for enrollment or factors that could lead to dropout or non-attendance (e.g., frequent job or residence changes); 5) individuals currently participating in other drug trials or clinical studies, or who have recently completed another clinical study or drug trial with a duration of less than 3 months; 6) individuals with a history of allergies or an allergy to the components of the study medication.

Design outcomes

Primary

MeasureTime frame
Thyroid nodule count;Thyroid nodule location;Thyroid nodule maximum diameter;Thyroid nodule volume;Thyroid nodule border;Thyroid nodule echogenicity;Thyroid nodule calcification;Thyroid nodule blood flow signal;

Countries

China

Contacts

Public ContactXie Chengcheng

Shenzhen Luohu Traditional Chinese Medicine Hospital

346772731@qq.com+86 132 6542 0468

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026